Standout Papers
Immediate Impact
2 hit
Citing Papers
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
2024 Hit
Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
2024 Hit
Works of Rakesh Dhar being referenced
Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults
2024 Hit
Safety, Tolerability, and Immunogenicity of an mRNA-Based Respiratory Syncytial Virus Vaccine in Healthy Young Adults in a Phase 1 Clinical Trial
2024
Author Peers
Peers are selected by citation overlap in the author's most active subfields. citations · hero ref
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Rakesh Dhar | 62 | 52 | 18 | 17 | 13 | 9 | 96 | |
| Scott A. Rush | 90 1.5× | 78 1.5× | 17 0.9× | 6 0.4× | 14 1.1× | 9 | 125 | |
| Karla R. Navarro-Fuentes | 35 0.6× | 38 0.7× | 11 0.6× | 12 0.7× | 8 0.6× | 6 | 90 | |
| Iría Miguens | 37 0.6× | 39 0.8× | 5 0.3× | 20 1.2× | 4 0.3× | 10 | 83 | |
| Charlotte Vernhes | 107 1.7× | 37 0.7× | 18 1.0× | 37 2.2× | 5 0.4× | 9 | 145 | |
| Elena V. Shidlovskaya | 19 0.3× | 64 1.2× | 22 1.2× | 12 0.7× | 4 0.3× | 13 | 89 | |
| Karlijn van der Straten | 19 0.3× | 75 1.4× | 13 0.7× | 9 0.5× | 12 0.9× | 9 | 110 | |
| Gisèle Elana | 35 0.6× | 63 1.2× | 18 1.0× | 8 0.5× | 10 0.8× | 7 | 223 | |
| Jesse Miller | 96 1.5× | 111 2.1× | 32 1.8× | 11 0.6× | 11 0.8× | 10 | 218 | |
| IA Shulman | 84 1.4× | 15 0.3× | 16 0.9× | 13 0.8× | 12 0.9× | 13 | 245 | |
| Maria Overvad | 32 0.5× | 150 2.9× | 44 2.4× | 9 0.5× | 9 0.7× | 11 | 241 |
All Works
Loading papers...